Nuvantta is a specialized advisory firm focused on healthcare and life sciences. We work with founders, investors, and corporate teams to support early-stage decision-making across MedTech, Biotech, and HealthTech.
Our work is built around a simple principle: clarity brings progress. Whether it’s preparing for due diligence, entering a new market, or assessing a strategic opportunity, we help teams cut through complexity and focus on what matters most.
We bring structured thinking, objective analysis, and hands-on support to the points in your journey where clarity matters most.
I started Nuvantta after consistently seeing the same challenge across the healthcare and life sciences sector: innovative solutions often struggle to translate into viable, investable businesses.
Through my work with hospitals, consulting firms, and venture teams across the US, Middle East, and India, I saw this pattern repeat itself. Investors weren’t always sure how to assess complex technologies. Founders had promising ideas but found it difficult to communicate value or plan for growth. Corporates were open to partnerships, but often unsure which startups were genuinely aligned with their needs.
My background brings together experience in management consulting and venture capital. I’ve advised both public and private organizations, and evaluated more than 130 opportunities through due diligence, giving me a comprehensive view of what it takes to build value in healthcare and life sciences.
At Nuvantta, we offer tailored advisory services designed to support early- and growth-stage ventures.
Our expertise bridges the gap between scientific innovation and market success.
We deliver independent assessments that help investors make confident decisions and founders sharpen their story before they raise.
We help life sciences and healthcare ventures prioritise opportunities and scale effectively through pipeline assessment, market entry, commercial strategy, partnerships and portfolio optimisation.
We help CVCs and life science companies identify and assess ventures, and determine whether to build, buy, or partner.
